The effects of MK-801 upon local CBP after permanent middle cerebral artery (MCA) occlusion have been examined using [14C]iodoantipyrine autoradiogra phy in halothane-anaesthetised rats. MK-801 (0.5 mg kg-I i. v.) or saline was administered 30 min before MCA occlusion and CBP measured �40 min after occlu sion. In the hemisphere contralateral to the occluded MCA, MK-801 significantly reduced local CBP in 19 of the 22 regions examined from the levels in saline-treated rats. In the contralateral hemisphere, after treatment with MK-801, blood flow was reduced by an average of 37% with little variation in the magnitude of the reductions in different regions. In the hemisphere ipsilateral to MCA occlusion, MK-801 reduced CBP in almost every region located outside the territory of the occluded MCA. Within the territory of the occluded MCA, blood flow in the MK-801-treated rat did not significantly differ from
A wide range of therapeutic strategies have been used in humans and experimental animals with the aim of improving blood flow and substrate delivery to the ischaemic brain, but only a few have shown convincing clinical benefit (e.g., nimodipine in sub arachnoid haemorrhage) (Petruk et aI., 1988; Pick ard et aI., 1989) . Indeed there has been concern that increased blood flow to ischaemic brain tissue may have adverse consequences such as increased cere bral oedema (Harris et aI., 1982; Hossmann, 1982) .
The concept that blockade of excitatory amino values in vehicle-treated rats in any of the five cortical areas examined, although in the caudate nucleus there was a tendency for CBP to be lower in rats pretreated with MK-801. MK-801 had no effect on the amount of hypoperfused cerebral tissue (CBP <30 ml 100 g-I min -I) in the ipsilateral hemisphere at any coronal plane examined; e.g., at coronal plane anterior 7.2 mm, 51 ± 5% of the hemisphere displayed CBP of <30 ml 100 g-I min -I in saline-treated rats with MCA occlusion com pared with 52 ± 8% of the hemisphere in rats treated with MK-801 prior to MCA occlusion. Thus, the reported an tiischaemic effects of MK-801 in this model cannot be attributed to improvement of blood flow to the hypoper fused cerebral tissue. Key Words: Focal cerebral isch aemia-Glutamate-N-methyl-D-aspartate receptors MK-801.
acid receptors attenuates the transmembrane ionic fluxes that lead to neuronal death (Meldrum, 1985; Rothman and Olney, 1986 ) provides a therapeutic strategy that does not depend upon improvement in CBF. High concentrations of glutamate are neuro toxic (Lucas and Newhouse, 1957; Rothman and Olney, 1986) , and in cerebral ischaemia there is a massive release of glutamate into the extracellular compartment (Benveniste et aI., 1984; Drejer et aI., 1985; Hagberg et aI., 1985 Hagberg et aI., , 1987 . The administra tion of glutamate receptor antagonists can markedly reduce the amount of ischaemic brain damage, par ticularly in animal models of focal cerebral isch aemia (Simon et aI., 1984; Germano et aI., 1987; Gill et aI., 1987; Boast et aI., 1988; Coyle, 1989; Gotti et aI., 1988; Ozyurt et aI., 1988; Park et aI., 1988a,b; Swan et aI.) . Although glutamate and its receptor antagonists themselves may influence cerebral tis-sue perfusion, it is not known if cerebral circulatory alterations contribute to or confound the use of glu tamate antagonists in cerebral ischaemia.
We have recently demonstrated in the rat that the prior administration of MK -801, a noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors (Wong et al., 1988) , markedly reduces the amount of ischaemic brain damage after permanent occlusion of the proximal middle cerebral artery (MCA) (Park et al., 1988b) . We now report the effects of MK-801 upon local CBF in this model of focal cerebral ischaemia under the same experimental conditions.
MATERIALS AND METHODS

Surgical preparation
The investigations were carried out in adult male Sprague-Dawley rats, weighing 360-450 g. The rats were anaesthetised with 2% halothane and a tracheostomy was performed. The animals were mechanically ventilated with a nitrous oxide/oxygen mixture (70:30%) containing 0.5-1 % halothane. Polyethylene catheters (15 cm long) were inserted into both femoral arteries and one vein to permit the continuous monitoring of MABP, the repeated sampling of arterial blood, and the administration of drug and radioactive tracer. Inspired halothane concentration was adjusted to between 0.5 and 1 % to produce adequate anaesthesia and to maintain MABP above 80 mm Hg. Respiratory volume was adjusted to maintain arterial car bon dioxide tension (Pac02) between 34 and 41 mm Hg. Body temperature was monitored by a rectal thermome ter and the animals were maintained at normothermia (37°C) by external heating of the hind limbs and lower abdomen. All animals underwent subtemporal craniec tomy and exposure of the main trunk of the left MCA under the high magnification of an operating microscope (Tamura et al., 1981; Shigeno et al., 1985 ). The exposed artery was electrocauterised from its origin to its junction with the inferior cerebral vein.
Experimental protocols
The animals were divided into two groups: MCA oc clusion control (n = 4) and MCA occlusion with MK-801 pretreatment (n = 5). In the treated group, MK-801 (0.5 mg kg -I) was administered intravenously 30 min before MCA occlusion. MK-80l solution (0.5 mg ml-I in saline) was injected slowly over 2 min while the MABP was closely monitored. Control animals received a similar vol ume of saline (l ml kg-I). Arterial blood samples were taken immediately before the occlusion of the MCA and immediately before the measurement of CBF to deter mine Pac02, Pa02, pH, and plasma glucose concentration. The measurement of local CBF was performed between 30 and 50 min after MCA occlusion.
Measurement of local CBF
Local CBF was measured with the quantitative autora diographic technique using [14C]iodoantipyrine as tracer (Sakurada et al., 1978) . The administration of the tracer, sampling of arterial blood during measurement, and prep aration of autoradiographs were carried out in a manner similar to that described previously (Tamura et al., 1981; Gotoh et al., 1986) . 1989 Measurement of optical density was carried out with two different approaches, both of which employed a com puter-based densitometer system (Quantimet 970; Cam bridge Instruments). The first approach was to measure the optical density at 22 neuroanatomically predefined sites, identified according to the atlas of Konig and Klip pel (1963) . The optical densities were determined in re gions of interest (frame size 0.1-0.2 mm 2 depending on region) by taking the average of the results from four adjacent sections at each neuroanatomical locus. The sec ond approach was to determine the amount of cerebral tissue at various levels of CBF using a frequency distri bution analysis. The blood flow distribution was assessed in each hemisphere at three coronal planes, i.e., stereo tactic coordinates approximately anterior 7.2 mm (corre sponding to mid-caudate nucleus), anterior 6.1 mm (the plane containing the globus pallidus), and anterior 4.4 mm (a midthalamic plane). Each hemisphere was delineated on four adjacent sections and optical density thresholds were set that corresponded to 20 increments, each of 10 ml 100 g -1 min -1. The percentage area within each flow band was then determined. The median blood flow and the amount of hypoperfused tissue (i.e., CBF of <30 ml 100 g-I min -1) were calculated for each coronal plane.
With each densitometric approach, CBF was calculated from the 14C tissue concentration with a brain-blood par tition coefficient for iodoantipyrine of 0.8 (Sakurada et al., 1978) .
Statistical analysis
Values are expressed as means ± SEM. Differences between groups were evaluated by Student's t test. A p value of <0.05 was considered significant.
RESULTS
Cardiovascular and respiratory status
The administration of MK-801 effected an imme diate, marked reduction in MABP (from 99 ± 3 mm Hg prior to drug administration to 57 ± 3 mm Hg 2 min after administration; p < 0.01). Thereafter, MABP returned gradually toward its preadministra tion levels. At the time of MCA occlusion, MABP in MK-80l-treated rats was still 20% lower than its preadministration value, but at this stage was not significantly different from vehicle-treated controls. The cardiovascular effects of MK-80l in the present cerebral circulatory study were similar to those ob served in a parallel study in the same model of the neuroprotective effects of the drug (Park et al., 1988b) . The administration of saline did not alter MABP. There were no significant differences be tween the treatment and control group in the levels of any of the other monitored physiological vari ables (Table 1) .
CBF in neuroanatomically defined regions
In regions contralateral to MCA occlusion, MK-801 (0.5 mg kg-I ) caused widespread reductions in CBF with only the hippocampus (molecular layer), hypothalamus, and genu of the corpus callosum fail- Data are presented as means ± SEM. MCAO, data measured at time of occlusion of middle cerebral artery; CBF, data measured at time of CBF measurement. There were no significant differences between the vehicle-treated and MK-801-treated animals.
ing to display significant reductions ( Table 2 ). The proportionately greatest reduction after MK-801 was observed in the inferior colliculus (reduced by 48% from vehicle-treated controls) and the propor tionately smallest reduction was observed in the genu of the corpus callosum (reduced by 19% from vehicle-treated controls). However, the reductions in CBF in the contralateral hemisphere were rather homogeneous, with the magnitude of the blood flow reduction in most regions being similar to the un weighted average reduction of 37% from vehicle treated animals (Fig. 1) .
In regions ipsilateral to MCA occlusion, MK-801 administration resulted in significantly lower levels of CBF in 13 of the 22 regions. With a single excep tion (the ventromedial portion of the caudate nu cleus), the regions in this hemisphere in which tis-sue perfusion was significantly reduced with MK-801 treatment were located outside the territory of the occluded MCA. In regions in which the blood supply was derived from the occluded MCA [i.e., frontal, sensorimotor, parietal auditory, and visual cortices and caudate nucleus (dorsolateral)], there was no significant difference in blood flow in ve hicle-treated and MK-801-treated animals (Fig. 1) .
Frequency distribution analysis of CBF
Frequency distribution of CBF in each hemi sphere was analysed at three coronal planes, i.e., anterior 4. 4 mm (midthalamic level), anterior 6.1 mm (level of the globus pallidus), and anterior 7.2 mm (level of the caudate nucleus). In the contralat eral hemisphere, median CBF was significantly lower (by 30-32%) in MK-801-treated animals rela- Data are means ± SEM and expressed as ml 100 g-I min -I. MCAO -40 min prior to CBF determination. MK-801 (0.5 mg kg-I) administered 30 min prior to MCAO.
Unpaired t test was performed for comparison between control and MK-801 in each region: ap < 0.05; bp < 0.01; cp < 0.005; dp < 0.001. tive to vehicle-treated controls in each of the coro nal planes examined (Fig. 2) . In the ipsilateral hemi spheres, median CBF was lower in MK-801-treated animals at each coronal plane (anterior 7.2 mm by 17%; anterior 6.1 mm by 20%; anterior 4.4 mm by 31 %), although none of these changes achieved sta tistical significance (Fig. 2) . The amount of hypoperfused tissue (CBF of <30 ml 100 g-I min -I ) was not influenced by MK-801 treatment either in the core of MCA territory (e.g., anterior plane 7.2 mm) or in the periphery of MCA territory (e.g., coronal plane 4.4 mm anterior) ( Fig. 3) .
DISCUSSION
In a parallel study, using the same rat model of focal cerebral ischaemia and the same concentra tion of MK-801, we have demonstrated that the vol ume of cerebral tissue with ischaemic brain damage can be reduced by 40% and t h at pretreatment and postocclusion treatment, 30 min after occlusion, are equally effective (Park et aI., 1988b) . It should be emphasised that the present study was not designed to comprehensively characterise the cerebrovascu lar pharmacology of MK-801 upon which anaesthe sia and the effects of the agent upon arterial pres sure will have an impact. The sole purpose was to describe the alterations in local CBF under identical conditions to those in which MK-801 reduces isch aemic brain damage. The present study indicates that although MK-801 has marked effects on CBF, the effects of the drug on cerebral tissue perfusion are unlikely to contribute to its neuroprotective ef fects, which we described in this model (Park et aI., 1988b) .
There are a number of mechanisms by which NMDA antagonists such as MK-801 might alter CBF. NMDA antagonists may have a direct vaso motor effect on cerebral resistance vessels or may block any direct vascular effects that glutamate might possess; these agents might effect changes in cerebral oxidative metabolism with secondary alter ations in cerebral tissue perfusion; or they may modify the normal regulatory mechanisms such as autoregulation in response to changes in perfusion pressure.
Phencyclidine and (J'-opiate agonists effect con traction of isolated canine cerebral arteries (Altura and Altura, 1981; Altura et aI., 1983) , and many of these agents [e.g., (PCP), TCP, and ketamine] are now recognised to have effects at the NM DA operated ion channel at which MK-801 acts (Kemp et aI., 1987) . While it might be tempting to ascribe the reduction in CBF that we noted in the non ischaemic hemisphere with MK-801 to a direct va soconstrictor effect, three lines of evidence argue against such a view. First, very high concentrations of PCP and its analogues (100 IJ-M for half-maximal effects) are required to induce cerebral vasocon striction in vitro. Second, it has been argued that the action of MK-801 on (J'-sites contributes mini mally to its neuropharmacological effects (Wong et aI., 1988). Third, others have failed to identify va somotor effects of NMDA antagonists in vitro (Du verger et aI., 1987) or to establish the presence of binding sites for NMDA ligands in the cerebral vas culature (Beart et aI., 1988) . Glutamate has minimal direct effects on the cere bral vasculature (Toda, 1982; Duverger et aI., 1987) except at concentrations that are in excess of those achieved even in cerebral ischaemia (Benveniste et aI., 1984) . Recently, NMDA receptor activation has been demonstrated to lead to the generation, from neurones, of endothelial-derived relaxant factor (Garthwaite et aI., 1988) , a potent cerebral vasodi lator (Katusic et aI., 1984; Edvinsson et aI., 1985) . Blockade of NMDA receptors, resulting in reduced generation of endothelial-derived relaxant factor, might contribute to the reduced CBF observed in the present study. However, such a mechanism must be viewed as very speculative at the present time. The administration of MK-801 markedly al ters local cerebral glucose use in conscious and anaesthetised rats Nehls et aI., 1988; Kurumaji et aI., 1989) . The ef fects of MK-801 upon glucose use in rats anaesthe tised with halothane/nitrous oxide (the anaesthetic regimen in the present study) differ quantitatively and qualitatively from those observed in conscious rats; in anaesthetised rats significant reductions (14-40%) are observed in approximately one-third of the regions investigated, with no region display ing significant increases in glucose use. Thus, de pressed substrate demand after MK-801 administra tion in anaesthetised rats provides a partial expla nation for the decreases in CBF that we observed in nonischaemic regions.
The reductions in CBF with MK-801 in brain re gions outside the territory of the occluded MCA contrast with the minimal differences between the blood flows within the territory of the occluded MCA of saline and MK-801-treated rats. MK-801 had no effect on cortical blood flow in any of the five cortical areas of the occluded hemisphere, al though in the ipsilateral caudate nucleus, there was a tendency toward lower blood flow in the MK-801-treated animals. Impairment of autoregulation to changes in perfusion pressure often accompanies ischaemic insults (Hossmann, 1982) , and the lower blood flow to the neostriatum may be a conse quence of the moderate hypotension observed with MK-801 in halothane-anaesthetised rats (see also Park et aI., 1988a) . The maintenance of blood flow in the ischaemic cortex, i.e., site of the neuropro tective effects of MK-801 in this model, contrasts with the hypoperfusion observed in the rest of the CN S. In a rat model of global ischaemia, there was similarly no evidence that alterations in CBF con tributed to the antiischaemic effects of intrahippo campal injections of competitive NMDA antago nists (Swan et aI., 1988) . These observations are consistent with the hypothesis that NMDA antago nists are neuroprotective via an action on neuronal tissue rather than via any effects on the cerebral vasculature (Rothman and Olney, 1986 ). In con trast, the histopathological improvement that was observed with nimodipine in the rat MCA model could not be dissociated from an increase in blood flow toward the margins of MCA territory (Mo hamed et aI., 1985; Gotoh et aI., 1986) . In conclu sion, although MK-801 has marked effects on CBF in the anaesthetised rat, these do not contribute to (e.g., by attenuation of the ischaemic insult) or complicate (e.g., via steal phenomenon) the neuro protective effect of the drug in this model.
